학술논문
Management of common adverse events related to first-line dacomitinib use in EGFR mutation-positive non-small-cell lung cancer: A pooled safety analysis
Document Type
Article
Author
Source
In: Future Oncology . (Future Oncology, May 2019, 15(13):1481-1491)
Subject
Language
English
ISSN
17448301
14796694
14796694